IRME · As filed with the SEC

IR-Med cash flow statement, by quarter

The statement as IR-Med presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

Interim Condensed Consolidated Statements of Cash Flows (Unaudited) · USD thousands

USD thousandsQ2 2025†
3 months ended Jun 30, 2025
Q1 2025
3 months ended Mar 31, 2025
Q4 2024†
3 months ended Dec 31, 2024
Q3 2024†
3 months ended Sep 30, 2024
Q2 2024†
3 months ended Jun 30, 2024
Q1 2024
3 months ended Mar 31, 2024
Q4 2023†
3 months ended Dec 31, 2023
Q3 2023†
3 months ended Sep 30, 2023
Cash flows from operating activities
Net Income(701)†(773)(278)†(598)†(366)†(657)(1,271)†(1,179)†
Adjustments to reconcile loss for the period to net cash used in operating activities:
Total stock-based compensation87†54(18)†197†100†206424†383†
Depreciation Expense4†34†4†4†90†4†
Financial expenses (income), net————(6)†38†0†
Non-cash financial expenses (income)413†520——(6)†———
Decrease in accounts receivable3†46(24)†(15)†18†2734†16†
Change in Accounts Payable(50)†4057†10†(122)†5451†(35)†
Net cash used in operating activities(71)†(110)(261)†(395)†(372)†(358)(754)†(811)†
Purchase of property and equipment——————(1)†—
Net cash used in investing activities——————(1)†—
Cash flows from financing activities
Proceeds from Debt Issuance0†39——————
Repayment of short-term loan—(39)0†—————
Proceeds from Debt Issuance0†31——————
Net Cash from Financing Activities——0†40†——0†0†
Net cash provided by financing activities88†310†35†——0†0†
Effect of Exchange Rate on Cash(5)†1——2†(1)(2)†0†
Net decrease in cash and cash equivalents12†(78)(263)†(361)†345†(359)(757)†(812)†
Cash and cash equivalents as at the beginning of the period511293927534087671,5242,336
Cash and cash equivalents as at the end of the period63511293927534087671,524

† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.